Root Financial Partners’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$707 Buy
+38
New +$951 ﹤0.01% 3098
2026
Q2
– Sell
-29
Closed -$577 – 3358
2026
Q1
$577 Buy
+29
New +$499 ﹤0.01% 2819

Other funds holding BCAX

Root Financial Partners's BCAX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 38 shares worth $707. The stake represents ﹤0.01% of the portfolio and ranks #3098 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in BCAX as recently as Q1 2026.

Root Financial Partners first reported a position in BCAX in Q1 2026 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Root Financial Partners held 38 shares of Bicara Therapeutics worth $707 as of Q3 2026.
  • Bicara Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Bicara Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3098 holding.
  • Root Financial Partners first reported a position in Bicara Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.